CapsoVision (CV) vs Medtronic (MDT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CapsoVision (CV) has outperformed Medtronic (MDT) over the past year, gaining 38.9% versus a loss of 13.0%. Medtronic is the larger company by market cap ($112.24 billion vs $352.3 million), about 318.6 times the size. Medtronic pays a dividend yielding 3.25%, while CapsoVision does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CV | MDT |
|---|---|---|
| Share price | $6.62 | $87.75 |
| Market cap | $352.25M | $112.24B |
| 1-day change | +1.22% | +2.62% |
| YTD return | -38.82% | -10.98% |
| 1-year return | +38.85% | -13.04% |
| 5-year return | — | -33.06% |
| P/E ratio (TTM) | — | 21.56 |
| Forward P/E | — | 13.68 |
| EPS (TTM) | $-0.45 | $4.07 |
| Dividend yield | 0.00% | 3.25% |
| Annual dividend | $0.00 | $2.85 |
| Revenue (latest FY) | — | $36.36B |
| Revenue growth (YoY) | — | +8.43% |
| Net income (latest FY) | — | $4.80B |
| Gross margin | — | 65.02% |
| Operating margin | — | 17.78% |
| Net margin | — | 13.20% |
| 52-week high | $15.37 | $106.33 |
| 52-week low | $4.38 | $73.31 |
| Distance from 52-week high | -56.93% | -17.47% |
| Analyst consensus | strong_buy | buy |
| Avg. price target upside | +43.50% | +19.02% |
| Average volume | 158.10K | 11.49M |
| Shares outstanding | 53.21M | 1.28B |
| Employees | 99 | 95,000 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Medtronic is about 318.6 times larger than CapsoVision by market value ($112.24B vs $352.25M).
- CV has outperformed MDT by 51.9 percentage points over the past year.
- Medtronic offers a meaningfully higher dividend yield (3.25% vs 0.00%).
About CapsoVision
CV stock →CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 99 employees
About Medtronic
MDT stock →Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 95,000 employees
CV vs MDT FAQ
Which is bigger, CapsoVision or Medtronic?
Medtronic (MDT) is larger, with a market capitalization of $112.24B compared with $352.25M for CapsoVision (CV).
Which stock has performed better over the past year, CV or MDT?
CV returned +38.85% over the past 12 months, compared with -13.04% for MDT (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, CapsoVision or Medtronic?
Medtronic pays a dividend yielding 3.25%, while CapsoVision does not currently pay a regular dividend.
Are CapsoVision and Medtronic in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.